Entrada Therapeutics (TRDA) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.15
-0.91
-0.66
-0.42

Details

Expected EPS
-1.150257
Actual EPS
-0.94
Surprise EPS
0.21
Surprise Percent
+18.28%

Description

Entrada Therapeutics (TRDA) has reported earnings of -0.94 per share for Q1 2026.

0 Comments

Share your thoughts